Maravai Lifesciences Holdings Inc (MRVI)
EBITDA Growth
93.09%
Quarterly · Period ending:
MRVI EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported93.09%period ending
Latest reported93.09%period ending
MRVI Quarterly EBITDA YoY % (272.26% → 93.09%)
Year-over-year change
High-resolution chart · PNG
MRVI ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 93.0938% | |
| 139.3478% | |
| -101.4242% | |
| 84.8193% | |
| -643.1949% | |
| -1,504.1214% | |
| -103.0257% | |
| -3,648.4652% | |
| 75.2016% | |
| -87.8795% | |
| 489.711% | |
| -96.7116% | |
| -97.103% | |
| -89.8093% | |
| -23.4768% | |
| -23.9332% | |
| 16.7469% | |
| 72.9248% | |
| 412.9819% | |
| 217.9956% | |
| 1,003.7906% | |
| 148.1278% | |
| 272.2558% |